These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 9044069)
1. Strategies to mitigate mineralization in the bioprosthetic or homograft cusp and aortic wall. Levy RJ J Heart Valve Dis; 1997 Jan; 6(1):7-8. PubMed ID: 9044069 [No Abstract] [Full Text] [Related]
2. Prevention of calcification of bioprosthetic heart valve cusp and aortic wall with ethanol and aluminum chloride. Clark JN; Ogle MF; Ashworth P; Bianco RW; Levy RJ Ann Thorac Surg; 2005 Mar; 79(3):897-904. PubMed ID: 15734402 [TBL] [Abstract][Full Text] [Related]
3. The No-React anticalcification treatment: a comparison of Biocor No-React II and Toronto SPV stentless bioprostheses implanted in sheep. Herijgers P; Ozaki S; Verbeken E; Van Lommel A; Jashari R; Nishida T; Leunens V; Flameng W Semin Thorac Cardiovasc Surg; 1999 Oct; 11(4 Suppl 1):171-5. PubMed ID: 10660187 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of cusp and aortic wall calcification in ethanol- and aluminum-treated bioprosthetic heart valves in sheep: background, mechanisms, and synergism. Levy RJ; Vyavahare N; Ogle M; Ashworth P; Bianco R; Schoen FJ J Heart Valve Dis; 2003 Mar; 12(2):209-16; discussion 216. PubMed ID: 12701794 [TBL] [Abstract][Full Text] [Related]
5. Aortic homograft: a suitable substitute for aortic valve replacement. Talwar S; Mohapatra R; Saxena A; Singh R; Kumar AS Ann Thorac Surg; 2005 Sep; 80(3):832-8. PubMed ID: 16122437 [TBL] [Abstract][Full Text] [Related]
6. Antimineralization treatments for bioprosthetic heart valves. Assessment of efficacy and safety. Schoen FJ; Levy RJ; Hilbert SL; Bianco RW J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1285-8. PubMed ID: 1434707 [TBL] [Abstract][Full Text] [Related]
7. The failure modes of biological prosthetic heart valves. Butany J; Leask R J Long Term Eff Med Implants; 2001; 11(3-4):115-35. PubMed ID: 11921659 [TBL] [Abstract][Full Text] [Related]
8. The homograft aortic valve: a 29-year, 99.3% follow up of 1,022 valve replacements. O'Brien MF; Harrocks S; Stafford EG; Gardner MA; Pohlner PG; Tesar PJ; Stephens F J Heart Valve Dis; 2001 May; 10(3):334-44; discussion 335. PubMed ID: 11380096 [TBL] [Abstract][Full Text] [Related]